Lv11
100 积分 2022-11-03 加入
Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study
6小时前
求助中
Safety Implications of Switching Pembrolizumab Dosage From 200 mg Every 3 Weeks to 400 mg Every 6 Weeks in Patients With Advanced NSCLC
7小时前
已完结
A phase II, randomized, open-label study to evaluate low-dose pembrolizumab plus chemotherapy versus chemotherapy as neoadjuvant therapy for localized triple-negative breast cancer (TNBC) (PLANeT trial—Pembrolizumab Low dose in Addition to NACT in TNBC)
8小时前
已完结
Pregnancy After Breast Cancer in Young BRCA Carriers
7个月前
已完结
TET1 regulates stem cell properties and cell cycle of Cancer stem cells in triple-negative breast cancer via DNA demethylation
7个月前
已完结
Endocrine Therapy Interruption, Resumption, and Outcomes Associated With Pregnancy After Breast Cancer
8个月前
已完结
Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis
8个月前
已完结
Updates in the pathology of Pregnancy Associated Breast Cancer (PABC)
9个月前
已完结
皖公网安备34019202002308
